Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer

Conclusions: Our study provides evidence that DACT-2 may be a useful biomarker for distinguishing prostate tumor tissues from non-cancerous samples and a potential target for epigenetic silencing in primary prostate Cancer.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Shibao Li, Lingyu Yin, Kai Huang, Yao zhao, Haoliang Zhang, Chenchen Cai, Yinhai Xu, Lingyan Huang, Xiaozhou Wang, Ting Lan, Hongchun Li, Ping Ma Tags: Research Paper Source Type: research